| Literature DB >> 28242107 |
Hiroyoshi Takeuchi1, Sadhana Thiyanavadivel2, Ofer Agid3, Gary Remington4.
Abstract
To address whether wait discontinuation (i.e., introducing the new antipsychotic while maintaining the first for a period before initiating its discontinuation) is superior to non-wait discontinuation (i.e., initiating the first antipsychotic's discontinuation when introducing the new antipsychotic) in antipsychotic switching, we conducted a meta-analysis of randomized controlled trials comparing gradual vs. wait-and-gradual antipsychotic discontinuation in patients with schizophrenia. The meta-analysis of 5 studies (n=410) demonstrated no significant differences in any clinical outcomes, including study discontinuation, psychopathology, extrapyramidal symptoms, and treatment-emergent adverse events, between the two groups. These findings indicate either strategy can be used in clinical practice.Entities:
Keywords: Antipsychotics; Discontinuation; Schizophrenia; Switching strategy
Mesh:
Substances:
Year: 2017 PMID: 28242107 DOI: 10.1016/j.schres.2017.02.011
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939